Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Tumor responses in phase II study of CA4P, paclitaxel and carboplatin

Jan. 3, 2007

Partial responses in pancreatic cancer study of glufosfamide plus gemcitabine

Jan. 3, 2007

Bioequivalence study of ANX-530 cleared to begin

Jan. 3, 2007

SKI-606 active in chronic myelogenous leukemia in phase I study

Jan. 3, 2007

KRX-0401 studied with Revlimid and dexamethasone for multiple myeloma

Jan. 2, 2007

Bioenvision prepares MAA for Evoltra in AML

Jan. 2, 2007

KSP inhibitor ARRY-520 to begin clinical testing

Jan. 2, 2007

Sunitinib filed in Japan for renal carcinoma and gastrointestinal stromal tumors

Jan. 2, 2007

ThromboGenics and BioInvent receive funding for antiangiogenesis program

Jan. 2, 2007

CoFactor and 5-FU studied in refractory metastatic breast cancer

Jan. 2, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...